# Sinovac Biotech Co., Ltd clinical trials: 93 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 93 trials with Sinovac Biotech Co., Ltd as lead sponsor, 17 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sinovac Biotech Co., Ltd: 93 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sinovac-biotech-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 93
- Recruiting or not yet: 17
- Read on: November 19, 2026

## Trials

The 25 newest of 93, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07889219 | Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine | Sinovac Biotech Co., Ltd | Observational | Recruiting | Hepatitis A | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889219) |
| October 22, 2026 | NCT07889193 | Phase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell) | Sinovac Biotech Co., Ltd | Phase 1 | Not yet recruiting | Seasonal Influenza | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889193) |
| October 2, 2026 | NCT07855705 | A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine | Sinovac Biotech Co., Ltd | Observational | Completed | Hepatitis A | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855705) |
| September 21, 2026 | NCT07832201 | A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) | Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | Influenza | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832201) |
| August 28, 2026 | NCT07793227 | Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine | Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | Hepatitis A Vaccine | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793227) |
| August 28, 2026 | NCT07793175 | Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children | Sinovac Biotech Co., Ltd | Not applicable | Not yet recruiting | Hand, Foot, and Mouth Disease (HFMD), Enterovirus 71 Infection | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793175) |
| July 30, 2026 | NCT07737106 | Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose) | Sinovac Biotech Co., Ltd | Phase 1 | Completed | Influenza | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737106) |
| May 28, 2026 | NCT07611513 | Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | Hand, Foot, and Mouth Disease(HFMD), Herpangina | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611513) |
| April 1, 2026 | NCT07505888 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years | Sinovac Biotech Co., Ltd | Phase 3 | Active not recruiting | Epidemic Meningitis, Meningococcal Vaccines | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505888) |
| April 1, 2026 | NCT07505836 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months | Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | Epidemic Meningitis, Meningococcal Vaccines | 1,040 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505836) |
| April 1, 2026 | NCT07505823 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months | Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | Epidemic Meningitis, Meningococcal Vaccines | 1,040 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505823) |
| April 1, 2026 | NCT07505810 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months | Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | Epidemic Meningitis, Meningococcal Vaccines | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505810) |
| March 9, 2026 | NCT07457060 | Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | Poliomyelitis | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457060) |
| February 18, 2026 | NCT07418229 | Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine | Sinovac Biotech Co., Ltd | Phase 1 | Not yet recruiting | RSV, mRNA Vaccine | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07418229) |
| February 17, 2026 | NCT07416110 | Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine | Sinovac Biotech Co., Ltd | Phase 3 | Active not recruiting | Rabies (Healthy Volunteers) | 912 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416110) |
| February 10, 2026 | NCT07400003 | Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine | Sinovac Biotech Co., Ltd | Phase 1/2 | Recruiting | Herpes Zoster, mRNA Vaccine | 519 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400003) |
| January 22, 2026 | NCT07357545 | Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried | Sinovac Biotech Co., Ltd | Phase 3 | Completed | Rabies (Healthy Volunteers) | 2,040 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07357545) |
| January 21, 2026 | NCT07354269 | Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations | Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | Poliomyelitis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354269) |
| October 7, 2025 | NCT07211152 | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women | Sinovac Biotech Co., Ltd | Phase 3 | Completed | Influenza | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07211152) |
| July 17, 2025 | NCT07071701 | A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population | Sinovac Biotech Co., Ltd | Observational | Completed | Pneumococcal Infectious Disease | 19,267 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07071701) |
| July 9, 2025 | NCT07055893 | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen | Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | Rabies (Healthy Volunteers) | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07055893) |
| July 9, 2025 | NCT07055880 | Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) | Sinovac Biotech Co., Ltd | Phase 2 | Not yet recruiting | Rabies | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07055880) |
| July 8, 2025 | NCT07055295 | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen | Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | Rabies | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07055295) |
| June 18, 2025 | NCT07026500 | Clinical Trial for Batch Consistency of EV71 Vaccine | Sinovac Biotech Co., Ltd | Phase 4 | Completed | EV71 Vaccine | 720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07026500) |
| December 31, 2024 | NCT06754384 | Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Sinovac Biotech Co., Ltd | Phase 1/2 | Completed | Hand, Foot, and Mouth Disease (HFMD), Herpangina | 552 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06754384) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 1/2 | 4 |
| Phase 2 | 6 |
| Phase 3 | 27 |
| Phase 4 | 35 |
| Not applicable | 2 |
| Observational | 11 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 66 |
| Recruiting | 10 |
| Not yet recruiting | 7 |
| Unknown | 6 |
| Active not recruiting | 3 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hand, Foot and Mouth Disease | 20 |
| Influenza, Human | 17 |
| Poliomyelitis | 15 |
| Hepatitis A | 8 |
| Pneumococcal Infections | 5 |
| Rabies | 5 |
| Meningitis, Meningococcal | 4 |
| Infections | 4 |
| Enterovirus Infections | 4 |
| COVID-19 | 3 |
| Herpangina | 3 |
| Hepatitis | 2 |
| Hepatitis B | 2 |
| Herpes Zoster | 1 |
| Pneumonia | 1 |
| Mumps | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B energy and utility companies in the United States](https://specstream.ai/data/businesses/b2b-energy-and-utility-companies/united-states)
- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
- [Geological services in the United States](https://specstream.ai/data/businesses/geological-services/united-states)
- [B2B quarry companies in the United States](https://specstream.ai/data/businesses/b2b-quarry-companies/united-states)
- [Pubs in the United States](https://specstream.ai/data/businesses/pubs/united-states)
- [Handyman services in the United States](https://specstream.ai/data/businesses/handyman-services/united-states)
